Individualized peptide consultation
The practice advertises consultation-led peptide planning and follow-up rather than a fixed public protocol.
Provider source ↗Lawrenceburg, KY · Telehealth available
Provider overview
NP Modalities publishes two Kentucky offices and virtual-visit pages for Kentucky, West Virginia, and Florida. Its peptide materials name BPC-157, TB-500, CJC-1295 with ipamorelin, sermorelin, and bremelanotide (PT-141), alongside weight, hormone, thyroid, and inflammation-focused programs. These are provider-reported offerings; the profile does not establish a compound's approval status, availability, safety, effectiveness, or suitability for an individual.
At a glance
503A and 503B labels describe statutory compounding pathways or public relationships. They do not mean a compounded drug is FDA-approved or that FDA endorses a facility.
Service catalog
Provider-advertised services, grouped for quick scanning with all details visible.
The practice advertises consultation-led peptide planning and follow-up rather than a fixed public protocol.
Provider source ↗The provider names these research-associated peptides in recovery-oriented educational materials; current clinical availability and regulatory status should be confirmed directly.
Provider source ↗This combination is named in provider-published peptide materials without an editorial claim about approval or benefit.
Provider source ↗The practice publishes a sermorelin pathway that includes laboratory review and follow-up monitoring.
Provider source ↗The practice names bremelanotide in sexual-health-oriented peptide content; formulation and eligibility are not independently verified.
Provider source ↗Personalized weight-management care is listed among the practice's core services.
Provider source ↗The official services page lists hormone replacement, testosterone care, and thyroid management.
Provider source ↗Vitamin injections are advertised as a separate office-based service.
Provider source ↗Coverage and research
Review every state page this provider advertises serving, then use the related guides to evaluate services and claims.
Continue comparing
Evidence
Logo reproduced from the provider’s official website for identification. Logo source ↗
These links support the public facts recorded here. Provider-published information is not an independent endorsement.
Supports: identity contact locations and care model · Checked Aug 1, 2026
Supports: services and treatment categories · Checked Aug 1, 2026
Supports: specific peptides laboratory review and monitoring · Checked Aug 1, 2026
Supports: multistate telehealth · Checked Aug 1, 2026